September 2026
The global sickle cell disease treatment market size is predicted to hit around USD 15.81 billion by 2035 from USD 4.35 billion in 2026 with a CAGR of 15.48%.
September 2026
The global inflammatory bowel disease treatment market size is projected to hit around USD 32.46 billion by 2035 from USD 22.38 billion in 2025, with a CAGR of 3.79%.
September 2026
The global periodontal disease treatment market size was evaluated at USD 3.17 billion in 2026 and is predicted to hit around USD 6.23 billion by 2035, growing at a CAGR of 7.80%.
June 2026
The global celiac disease treatment market size is evaluated at USD 784.59 million in 2025 and is predicted to hit around USD 2,400.49 million by 2035, growing at a CAGR of 11.83%.
June 2026
The rare diseases treatment market size was estimated at USD 244.57 billion in 2025 and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
January 2026
The cellulite treatment market size was reached at USD 2.40 billion in 2025 and it is expected to surpass around USD 7.42 billion by 2035 with a CAGR of 10.72%.
January 2026
The global fabry disease treatment market size reached USD 2.45 billion in 2025 and is estimated to hit around USD 5.20 billion by 2035 with a CAGR of 7.82%.
December 2025
The chronic obstructive pulmonary disease treatment market size is expected to hit around USD 33.03 billion by 2035 from USD 21.04 billion in 2025 at a CAGR of 5.14%.
July 2025
The global hearing loss disease treatment market reached USD 14.43 billion in 2024 and is projected to surpass around USD 24.03 billion by 2034 with a CAGR of 5.23%.
June 2025
The global peripheral arterial disease treatment market size is estimated to hit around USD 6.11 billion by 2034 from USD 3.41 billion in 2026, with a CAGR of 7.56%.
September 2026
The infectious respiratory disease diagnostics market size was USD 60.62 billion in 2026, with leading infectious respiratory disease diagnostics market players including F. Hoffmann - La Roche, Thermo Fisher Scientific, Danaher (Cepheid), Abbott LaboratoriesÂ
September 2026
The global single cell sequencing market size is estimated to hit around USD 11.09 billion by 2035, increasing from USD 3.24 billion in 2026, with a CAGR of 14.67%.
September 2026
The cell penetrating peptide market size was estimated at USD 2.88 billion in 2026 and is expected to hit around USD 9.95 billion by 2035, growing at a CAGR of 14.9%.
September 2026
The global live cell imaging market size is calculated at USD 3.56 billion in 2026 and is projected to hit around USD 7.22 billion by 2035 with a CAGR of 8.21%.
September 2026
The orphan disease biomarkers market expands with advancements in genomics, proteomics, and bioinformatics for rare conditions.
September 2026
The global cell cryopreservation market size is valued at USD 1,818.3 million in 2026 and is projected to hit around USD 5,028.90 million by 2035 with a CAGR of 11.85%.
September 2026
The global sexually transmitted diseases diagnostics market size is estimated to hit around USD 21.44 billion by 2034 from USD 12.26 billion in 2026, with a CAGR of 7.24%.
September 2026
The synthetic stem cells market size stood at USD 11.25 billion in 2026, with major synthetic stem cells market companies including Brainstorm Cell Therapeutics, Fate Therapeutics, Evotec, Cesca Therapeutics, VistaGen Therapeutics.
September 2026
The extracellular matrix patches market reached USD 50.95 million in 2026, with key extracellular matrix patches market companies including Admedus Ltd., Aziyo Biologics, Baxter, Boston Scientific Corporation, Coloplast Group, Cook Group.
September 2026
The global enteric disease testing market size was evaluated at USD 4.58 billion in 2026 and is predicted to hit around USD 8.09 billion by 2035, growing at a CAGR of 6.52%.
September 2026
The t-cell engagers market was valued at USD 8.89 billion in 2026, with leading companies including Amgen Inc., AstraZeneca plc, Roche (Genentech), Johnson & Johnson (Janssen).
September 2026
The global inflammatory disease market size was evaluated at USD 133.50 billion in 2026 and is predicted to hit around USD 241.34 billion by 2035, growing at a CAGR of 6.80%.
September 2026
The b-cell maturation antigen (BCMA) targeted therapies market size reached USD 6.62 billion in 2026, with leading B-Cell Maturation Antigen (BCMA) Targeted Therapies Market companies including Bristol Myers Squibb, Johnson & Johnson, GSK plc, Amgen Inc., Regeneron Pharmaceuticals, Inc.
September 2026
The automation, digitization and robotics in cell and gene therapy manufacturing market reached USD 1,127.65 million in 2026, with key automation, digitization and robotics in cell and gene therapy manufacturing market companies including Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation (Cytiva), Lonza Group AG.
September 2026
The global large-scale active stem cell clinical trials market size was evaluated at USD 8.27 billion in 2026 and is predicted to hit around USD 28.88 billion by 2035, growing at a CAGR of 14.90%.
September 2026
The hematopoietic stem cell transplantation market size reached USD 12.69 billion in 2026, with leading hematopoietic stem cell transplantation market companies including Novartis, Gilead Sciences, Baxter International, Fresenius Kabi.
September 2026
The parkinsons disease biomarkers market size reached USD 1.54 billion in 2026, with leading parkinsons disease biomarkers market companies including F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Thermo Fisher Scientific, Abbott Laboratories.
September 2026
The global Alzheimers disease diagnostics market size was evaluated at USD 10.42 billion in 2026 and is predicted to hit around USD 26.21 billion by 2035, growing at a CAGR of 10.80%.
September 2026
The U.S. cell therapy manufacturing market was worth USD 1.97 billion in 2026, with key U.S. cell therapy manufacturing market players including Merck KGaA, Thermo Fisher Scientific, Catalent, Inc.
September 2026
The global Huntingtons disease market size was evaluated at USD 1.66 billion in 2026 and is predicted to hit around USD 6.48 billion by 2035, growing at a CAGR of 17.20%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com